PRAGUE, June 7, 2024 /PRNewswire/ -- Stimvia, a pioneering medical technology company specializing in neuromodulation for chronic disease treatment, has successfully completed its pilot study focused on Parkinson's Disease (PD) and is expecting promising results. "We are pleased to share preliminary findings indicating promising results Continue reading →

Israeli startup Remepy is on a mission to transform the treatment of conditions such as Parkinsons disease and cancer with hybrid drugs that combine traditional medicine with smartphone applications. That combination of medicine and software is what Remepy refers to as digital molecules custom-tailored phone apps designed to engage specific neuro-immune processes in the body. Continue reading →

Parkinsons disease is a neurodegenerative movement disorder that progresses relentlessly. It gradually impairs a persons ability to function until they ultimately become immobile and often develop dementia. Continue reading →

Observing brain cell activity in real time using sophisticated imaging methods has captivated the attention of Guohong Cui, M.D., Ph.D., since he joined NIEHS in 2014. Today, the recently tenured scientist and In Vivo Neurobiology Group leader explores how movement is controlled in animal models to improve understanding of and treatment for neurodegenerative conditions, such as Parkinsons disease. Parkinsons disease results from the degeneration of neurons in the brain that produce the chemical messenger dopamine Continue reading →

Heavy coffee consumption results in lower dopamine activity in the striatum, a brain region affected in Parkinsons disease, and does not ease motor symptoms in early diagnosed patients who have not yet been treated for the neurological disease, a study has found. However, coffee consumption before brain imaging was seen to influence results, with a temporary enhancement of dopamine activity in the brain. Clinicians should consider caffeines potential influence on [dopamine] imaging results and incorporate appropriate guidelines for caffeine abstinence prior to imaging, researchers wrote in the study Dietary Caffeine and Brain Dopaminergic Function in Parkinson Disease, which was published in the journal Annals of Neurology Continue reading →

Recognizing cognitive decline and low sex drive in people with Parkinsons disease and depression could aid the early diagnosis and better management of the disease, according to researchers in Iran. While its not known if treating depression may ease other nonmotor symptoms, these findings could be beneficial for early diagnosis of the disease, which eventually could make a considerable difference in the management of [Parkinsons], the researchers wrote in Depression is associated with the nonmotor symptoms of Parkinsons disease: A comparative analysis, which was published in Health Science Reports Continue reading →